EZH2 inhibition overcomes immunomodulatory drug resistance in multiple myeloma via a cereblon-dependent pathway.
Saved in:
| Title: | EZH2 inhibition overcomes immunomodulatory drug resistance in multiple myeloma via a cereblon-dependent pathway. |
|---|---|
| Authors: | Li Y; The Institute of Cancer Research., Wilson A; The Institute of Cancer Research., Chrisochoidou Y; The Institute of Cancer Research., Martin S; The Institute of Cancer Research., Bird S; The Institute of Cancer Research, London; The Royal Marsden Hospital NHS Foundation Trust., Morales S; The Institute of Cancer Research., Leiro M; The Institute of Cancer Research., Kozik Z; The Institute of Cancer Research., Crump NT; Hugh and Josseline Langmuir Centre for Myeloma Research, Centre for Haematology, Department of Immunology and Inflammation, Imperial College London., Roumeliotis TI; The Institute of Cancer Research., Choudhary J; The Institute of Cancer Research., Pawlyn C; The Institute of Cancer Research, London; The Royal Marsden Hospital NHS Foundation Trust. charlotte.pawlyn@icr.ac.uk. |
| Source: | Haematologica [Haematologica] 2026 Feb 12. Date of Electronic Publication: 2026 Feb 12. |
| Publication Type: | Journal Article |
| Journal Info: | Publisher: Ferrata Storti Foundation Country of Publication: Italy NLM ID: 0417435 Publication Model: Print-Electronic Cited Medium: Internet ISSN: 1592-8721 (Electronic) Linking ISSN: 03906078 NLM ISO Abbreviation: Haematologica Subsets: MEDLINE |
| Database: | MEDLINE Ultimate |
Be the first to leave a comment!
